DescriptionSources: http://www.drugbank.ca/drugs/DB01152Curator's Comment: description was created based on several sources, including:
http://www.ncbi.nlm.nih.gov/pubmed/773298
Sources: http://www.drugbank.ca/drugs/DB01152
Curator's Comment: description was created based on several sources, including:
http://www.ncbi.nlm.nih.gov/pubmed/773298
This bioactive compound was named candicidin, because of its high activity on Candida albicans. Candicidin is a polyene antifungal antibiotic produced by a strain of Streptomyces griseus. It is especially effective against Candida albicans (more effective than amphotericin B), and is administered intravaginally in the treatment of vulvovaginal candidiasis. Candicidin inhibits cell membrane of Candida albicans, resulting in disruption of membrane integrity and ultimately cell death. There is some evidence that the binding site in the cell wall may be to fatty acids or fatty acid esters and that this binding capacity must be satisfied before candicidin can bring about its lethal effect by binding to sterol in the cell membrane.
Originator
Approval Year
Sample Use Guides
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/5320588
Candicidin inhibits the growth of a large number of fungi. It inhibits Candida species with 0.5 ug/ml to 50 ug/ml
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C258
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
||
|
WHO-VATC |
QG01AA04
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
||
|
WHO-ATC |
G01AA04
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
94219
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY | |||
|
100000084867
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY | |||
|
2013
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY | |||
|
C87461
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY | |||
|
DTXSID301014435
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY | |||
|
CANDICIDIN
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY | |||
|
CHEMBL2108379
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY | |||
|
48N2IYJ202
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY | |||
|
11014-70-3
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
ALTERNATIVE | |||
|
D002174
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY | |||
|
m3013
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY | Merck Index | ||
|
1402-88-6
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
ALTERNATIVE | |||
|
4424
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY | |||
|
215-763-7
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY | |||
|
DB01152
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY | |||
|
1403-17-4
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY | |||
|
759868
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY | |||
|
SUB01021MIG
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY | |||
|
CHEMBL1200647
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY | |||
|
354984
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY | |||
|
1822
Created by
admin on Mon Mar 31 23:24:53 GMT 2025 , Edited by admin on Mon Mar 31 23:24:53 GMT 2025
|
PRIMARY |
All of the following components must be present:
ACTIVE MOIETY